BME (Blackrock Health Sciences Trust) Research & Development: $0.00 Mil (TTM As of Dec. 2025)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

BME Blackrock Health Sciences Trust BME
39 GF Score
Price $45.80
! 4 Warning Signs
View Full Analysis

What is Blackrock Health Sciences Trust Research & Development?

Blackrock Health Sciences Trust BME +0.37% 39 Research & Development is $0.00 Mil as of Dec. 2025. GuruFocus rates BME with a GF Score™ of 39/100. The stock has 4 warning signs investors should review.

Research & Development is the aggregate amount of research and development expenses during the year. Blackrock Health Sciences Trust's Research & Development for the six months ended in Dec. 2025 was $0.00 Mil. Its Research & Development for the trailing twelve months (TTM) ended in Dec. 2025 was $0.00 Mil.

Blackrock Health Sciences Trust  (NYSE:BME) Research & Development Explanation

If competitive advantage is created by a patent or tech advantage, at some point it will disappear.

High R&D usually dictates high SG&A which threatens the competitive advantage.

Blackrock Health Sciences Trust Research & Development Related Terms

Blackrock Health Sciences Trust Research & Development Historical Data

* Premium members only.

The historical data trend for Blackrock Health Sciences Trust's Research & Development can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Blackrock Health Sciences Trust Research & Development Chart

Blackrock Health Sciences Trust Annual Data
Trend Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Research & Development
Get a 7-Day Free Trial Premium Member Only 0.00 0.00 0.00 0.00 0.00

Blackrock Health Sciences Trust Semi-Annual Data
Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
Research & Development Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00
BME
39GF Score
Blackrock Health Sciences Trust BME
Research & Development is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Blackrock Health Sciences Trust Research & Development Calculation

This is the expense the company spent on research and development.

Research & Development for the trailing twelve months (TTM) ended in Dec. 2025 adds up the semi-annually data reported by the company within the most recent 12 months, which was $0.00 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Research & Development →
What does a Research & Development of $0.00 Mil mean?
Blackrock Health Sciences Trust (BME) has a Research & Development of $0.00 Mil as of Dec. 2025. Research and development expense is the total cost for research and development activities. View historical data on Blackrock Health Sciences Trust and its competitors.
Is Blackrock Health Sciences Trust's Research & Development too high?
Blackrock Health Sciences Trust's current Research & Development is $0.00 Mil. Overall, Blackrock Health Sciences Trust has a GF Score™ of 39/100, reflecting its overall financial health beyond just this single metric.
How does Blackrock Health Sciences Trust's Research & Development compare to MMU and ETJ?
Blackrock Health Sciences Trust's Research & Development of $0.00 Mil can be compared against companies in the Asset Management industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Research & Development for an Asset Management company?
A good Research & Development depends on the Asset Management industry context. However, Research & Development should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Research & Development mean?
A high Research & Development can signal that a stock is expensive relative to its fundamentals. Research and development expense is the total cost for research and development activities. View historical data on Blackrock Health Sciences Trust and its competitors. Blackrock Health Sciences Trust's current Research & Development is $0.00 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Blackrock Health Sciences Trust stock overvalued right now?
Blackrock Health Sciences Trust (BME) has a current Research & Development of $0.00 Mil. The current Research & Development is $0.00 Mil. Blackrock Health Sciences Trust's overall GF Score™ is 39/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Research & Development calculated?
Research & Development is calculated from a company's financial statements. For Blackrock Health Sciences Trust (BME), the current Research & Development is $0.00 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Blackrock Health Sciences Trust Business Description

Address 100 Bellevue Parkway, Wilmington, DE, USA, 19809
Blackrock Health Sciences Trust has an investment objective to provide total return and income mainly through long-term capital appreciation. The Trust invests the majority of its total assets in equity securities of companies engaged in the health sciences and related industries and equity derivatives with exposure to the health sciences industry.
39GF Score

Get the complete analysis for BME

Research & Development is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$45.80
Price